
|Articles|December 1, 2012
- Pharmaceutical Executive-12-01-2012
- Volume 0
- Issue 0
Top Medical Innovations for 2013
Author(s)Ben Comer
Ben Comer profiles 10 innovative technologies designated as new and revolutionary tools for the treatment of disease and disability.
Advertisement
At the conclusion of the Cleveland Clinic's Medical Innovations Summit each year, 10 innovative technologies are unveiled before the audience, and designated as new and revolutionary tools for the treatment of disease and disability. Selections for the Top 10 are chosen by way of a process that includes personal interviews with over 100 senior Cleveland Clinic physicians. Here are a few of the technologies that made the cut for 2013.
Articles in this issue
over 13 years ago
Pharmaceutical Executive Digital Edition - December 2012over 13 years ago
Obamacare, Innovation and Pricingover 13 years ago
Germany's Price Reform Revolutionover 13 years ago
Transforming Drug Development: A Lilly–Covance Case Studyover 13 years ago
The Puzzle Master: EMA's Guido RasiAdvertisement
Advertisement
Advertisement
Trending on PharmExec
1
Beyond Amyloid, Part One (of two): Tau and Microglia Redefine the Alzheimer’s Pipeline
2
What the Peptide Advisory Vote Actually Means: Q&A with James LaValle
3
Hanmi Pharm Enters $2.3 Billion Licensing Agreement with Genentech for HM17321
4
Focusing on Asset Acquisition Over Building a Single Platform Technology
5




